Literature DB >> 18355811

Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats.

Akira Utagawa1, Jessie S Truettner, W Dalton Dietrich, Helen M Bramlett.   

Abstract

The proinflammatory cytokine interleukin-1beta (IL-1beta) is induced rapidly after traumatic brain injury (TBI) and contributes to the inflammatory events that lead to neuronal loss. Although an important source of IL-1beta is from the injured brain itself, in patients with multiple organ trauma (polytrauma) IL-1beta is also released into the bloodstream which may potentially influence brain vulnerability. The purpose of this study was to determine the effects of systemic inflammation induced by peripheral administration of IL-1beta on histopathological and behavioral outcome after moderate fluid percussion (FP) brain injury in rats. At 30 min or 24 h after TBI, saline, 20 mug/kg or 40 mug/kg of IL-1beta was injected (n=4-9/group) intraperitoneally (IP). Sham operated animals (n=9) received either saline or IL-1beta (20 or 40 mug/kg) injections. The somatosensory tactile placing test was administered at 1, 2 and 3 days posttrauma. IL-1beta-treated animals showed significant placing deficits compared to vehicle-treated TBI animals. Three days after injection, contusion areas and volumes were significantly increased (p<0.05) with both IL-1beta doses and at both treatment times compared to vehicle-treated animals. IL-1beta-treated rats showed more contusion injury and hippocampal neuronal damage as well as enhanced perivascular neutrophil accumulation. Cortical IL-1r1 mRNA increased as early as 1 h following TBI, peaking at 24 h and remained elevated 3 days posttrauma. These data show that the posttraumatic administration of IL-1beta significantly aggravates behavioral outcome and increases overall contusion volume after TBI. Increased systemic inflammatory processes, including extravasation of activated leukocytes and proinflammatory cytokines could participate in this detrimental outcome. Because peripherally circulating cytokines and other neurotoxic factors may be increased following multi-organ trauma, these findings may be important in targeting therapeutic interventions in this patient population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355811      PMCID: PMC2435258          DOI: 10.1016/j.expneurol.2008.02.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  45 in total

1.  Effect of neutropenia and granulocyte colony stimulating factor-induced neutrophilia on blood-brain barrier permeability and brain edema after traumatic brain injury in rats.

Authors:  M J Whalen; T M Carlos; S R Wisniewski; R S Clark; J A Mellick; D W Marion; P M Kochanek
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

2.  Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.

Authors:  Denis Gris; Daniel R Marsh; Mark A Oatway; Yuhua Chen; Eilis F Hamilton; Gregory A Dekaban; Lynne C Weaver
Journal:  J Neurosci       Date:  2004-04-21       Impact factor: 6.167

3.  Interleukin 1 as mediator of the acute-phase response.

Authors:  C A Dinarello
Journal:  Surv Immunol Res       Date:  1984

4.  The importance of brain temperature in alterations of the blood-brain barrier following cerebral ischemia.

Authors:  W D Dietrich; R Busto; M Halley; I Valdes
Journal:  J Neuropathol Exp Neurol       Date:  1990-09       Impact factor: 3.685

5.  Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist.

Authors:  Roya Tehranian; Siv Andell-Jonsson; Sara M Beni; Ido Yatsiv; Esther Shohami; Tamas Bartfai; Johan Lundkvist; Kerstin Iverfeldt
Journal:  J Neurotrauma       Date:  2002-08       Impact factor: 5.269

Review 6.  Cytokines and fever.

Authors:  Bruno Conti; Iustin Tabarean; Cristina Andrei; Tamas Bartfai
Journal:  Front Biosci       Date:  2004-05-01

7.  Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat.

Authors:  J K Relton; N J Rothwell
Journal:  Brain Res Bull       Date:  1992-08       Impact factor: 4.077

8.  Moderate hypothermia reduces blood-brain barrier disruption following traumatic brain injury in the rat.

Authors:  J Y Jiang; B G Lyeth; M Z Kapasi; L W Jenkins; J T Povlishock
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  The effects of early post-traumatic hyperthermia in female and ovariectomized rats.

Authors:  Takamoto Suzuki; Helen M Bramlett; Gladys Ruenes; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2004-07       Impact factor: 5.269

10.  Interleukin-1beta messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature.

Authors:  Kosaku Kinoshita; i Katina Chatzipanteli; Elizabeth Vitarbo; Jessie S Truettner; Ofelia F Alonso; W Dalton Dietrich
Journal:  Neurosurgery       Date:  2002-07       Impact factor: 4.654

View more
  43 in total

Review 1.  Scutellarin as a Potential Therapeutic Agent for Microglia-Mediated Neuroinflammation in Cerebral Ischemia.

Authors:  Yun Yuan; Ming Fang; Chun-Yun Wu; Eng-Ang Ling
Journal:  Neuromolecular Med       Date:  2016-04-21       Impact factor: 3.843

Review 2.  The far-reaching scope of neuroinflammation after traumatic brain injury.

Authors:  Dennis W Simon; Mandy J McGeachy; Hülya Bayır; Robert S B Clark; David J Loane; Patrick M Kochanek
Journal:  Nat Rev Neurol       Date:  2017-02-10       Impact factor: 42.937

Review 3.  The Influence of Systemic Immune Response and Sleep Modulation on the Secondary Effects of Traumatic Brain Injury in the Rodent Model.

Authors:  Carrie A Sheeler
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

4.  Suppressed cytokine expression immediatey following traumatic brain injury in neonatal rats indicates an expeditious endogenous anti-inflammatory response.

Authors:  Naoki Tajiri; Diana Hernandez; Sandra Acosta; Kazutaka Shinozuka; Hiroto Ishikawa; Jared Ehrhart; Theo Diamandis; Chiara Gonzales-Portillo; Mia C Borlongan; Jun Tan; Yuji Kaneko; Cesar V Borlongan
Journal:  Brain Res       Date:  2014-03-03       Impact factor: 3.252

5.  Impact of aging on the immune response to traumatic brain injury (AIm:TBI) study protocol.

Authors:  Hilaire J Thompson; Frederick Rivara; Kyra J Becker; Ronald Maier; Nancy Temkin
Journal:  Inj Prev       Date:  2019-09-03       Impact factor: 2.399

6.  Role of interleukin-1beta in postoperative cognitive dysfunction.

Authors:  Mario Cibelli; Antonio Rei Fidalgo; Niccolò Terrando; Daqing Ma; Claudia Monaco; Marc Feldmann; Masao Takata; Isobel J Lever; Jagdeep Nanchahal; Michael S Fanselow; Mervyn Maze
Journal:  Ann Neurol       Date:  2010-09       Impact factor: 10.422

Review 7.  Innate immune responses to trauma.

Authors:  Markus Huber-Lang; John D Lambris; Peter A Ward
Journal:  Nat Immunol       Date:  2018-03-05       Impact factor: 25.606

8.  Serum Amyloid A is Expressed in the Brain After Traumatic Brain Injury in a Sex-Dependent Manner.

Authors:  Sirena Soriano; Bridget Moffet; Evan Wicker; Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2020-02-14       Impact factor: 5.046

9.  Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats.

Authors:  Samah G Abdel Baki; Ben Schwab; Margalit Haber; André A Fenton; Peter J Bergold
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.